CPT-Pharmacometrics & Systems Pharmacology, published by WILEY, is a leading open access journal dedicated to advancing the fields of pharmacometrics and systems pharmacology. Since its inception in 2012, it has established itself as a vital resource for researchers and practitioners, boasting a remarkable impact factor and occupying prestigious Q1 quartiles in categories such as Cardiology and Cardiovascular Medicine, Modeling and Simulation, and Pharmacology (Medical). The journal covers a broad spectrum of topics aimed at enhancing the understanding of drug development, efficacy, and patient safety through innovative modeling and simulation approaches. With its consistent ranking in the top tiers of its field, CPT-Pharmacometrics & Systems Pharmacology provides invaluable insights and fosters scholarly dialogue among its audience, including researchers, educators, and students. The journal is accessible to all, promoting knowledge dissemination and collaborative growth in the pharmacology community.

PHARMACEUTICAL STATISTICS is a premier academic journal published by Wiley, focusing on the intersection of pharmacology and statistics. With the ISSN 1539-1604 and E-ISSN 1539-1612, this journal has established itself as a leading resource in the field since its inception in 2004, with a targeted convergence year extending to 2024. Notably, it ranks in the Q1 category for both pharmacology and statistics, reflecting its high impact and significance within these disciplines. The journal embraces a wide scope, encompassing statistical methodology and its application in pharmaceuticals, thus serving as an essential platform for researchers, professionals, and students committed to advancing their knowledge and practice. Its notable placement in Scopus rankings further reinforces its academic credibility, making it a valuable reference point for high-quality research. Although this journal does not currently offer open access options, it remains a vital source of insights and research advancements in the pharmaceutical sciences.

The International Journal of Biostatistics, published by Walter de Gruyter GmbH, stands as a critical platform for advancements in the fields of biostatistics and applied statistics in medicine. With an ISSN of 2194-573X and an E-ISSN of 1557-4679, this journal has gained recognition for its rigorous peer-reviewed articles that bridge theoretical statistics and its practical applications in health sciences, maintaining a commendable Q2 quartile ranking in both Medicine and Statistics categories as of 2023. Hosted in Germany, the journal's pivotal role lies in disseminating innovative research findings that guide public health decisions and inform healthcare policy, thus appealing to a diverse readership including researchers, healthcare professionals, and students. Although the journal operates under a subscription model, it remains committed to providing valuable insights into the statistical methods that support evidence-based medicine and improve health outcomes globally. For those engaged in the evolving landscape of biostatistics, the International Journal of Biostatistics serves as an indispensable resource through its comprehensive coverage from 2005 to 2024.

Expert Opinion on Investigational Drugs, published by Taylor & Francis Ltd, is a premier journal dedicated to the dissemination of high-quality, peer-reviewed research in the fields of pharmacology and medicine. As an integral part of the scientific community since its inception in 1994, this journal has established itself as a leading source of insightful analysis and expert commentary on emerging drug therapies, providing invaluable resources for researchers, clinicians, and healthcare professionals. With an impressive impact factor and ranking in the top quartile across multiple pharmacological categories, it remains a vital platform for discussing innovative drug developments and their clinical applications. Though it operates on a subscription basis, Expert Opinion on Investigational Drugs is crucial for anyone involved in pharmacological research and the drug development process, positioning itself at the forefront of medical advancements and offering critical insights into the rapid evolution of investigational therapies.

The Chilean Journal of Statistics is a vital resource for researchers, professionals, and students dedicated to the field of statistics and probability. Published by SOC CHILENA ESTADISTICA-SOCHE, this journal serves as a platform for the dissemination of innovative research and advancements in statistical methodologies, data analysis, and applications. With an ISSN of 0718-7912 and E-ISSN 0718-7920, the journal features contributions from the statistical community in Chile and beyond, reflecting its growing influence as evidenced by its classification in the Q3 quartile for 2023. Operating out of Chile, specifically from Santiago, the journal aims to converge its scope from 2019 to 2024 on providing high-quality, peer-reviewed articles that can inform and inspire academic and professional practices. While it is not an open-access journal, it remains a crucial outlet for impactful statistical research, fostering a deeper understanding of statistical concepts and their real-world applications.

Statistics in Biosciences is a distinguished journal published by Springer, focusing on the innovative interplay between statistical methodologies and biosciences. Established in 2009, this journal aims to provide a platform for the dissemination of cutting-edge research in statistical applications within biochemistry, genetics, and molecular biology. With an impressive impact factor and a distinguished ranking in multiple categories, including Q2 in Biochemistry, Genetics and Molecular Biology (miscellaneous) and Q3 in Statistics and Probability, it serves as a crucial resource for researchers, professionals, and students seeking to deepen their understanding of statistical applications in biological contexts. The journal is accessible through traditional subscription models, ensuring that high-quality research remains available to a wide audience. Featuring contributions that advance statistical theory and application in the biosciences, Statistics in Biosciences is committed to fostering collaboration and innovation in a rapidly evolving scientific landscape.

BIOSTATISTICS is a premier academic journal dedicated to the intersection of statistical methodologies and their applications in the field of biomedicine, published by Oxford University Press. With its ISSN 1465-4644 and E-ISSN 1468-4357, the journal has established itself as a crucial resource for researchers and professionals in the broad disciplines of statistics and probability, particularly within medical contexts. The journal proudly holds a Q1 ranking in multiple categories as of 2023, including Medicine (miscellaneous), Statistics and Probability, as well as Statistics, Probability, and Uncertainty, placing it at the forefront of statistical research. It has also achieved notable Scopus rankings, underscoring its influence and reach—ranking 27th in Mathematics (Statistics and Probability) and 94th in Medicine (General Medicine). Although it does not currently offer open access options, BIOSTATISTICS remains committed to advancing scholarly conversation and innovation in statistical science, making it an essential outlet for both established and emerging researchers. With contributions spanning from 2003 to 2024, this journal is actively seeking to foster an understanding of complex statistical approaches in biomedicine, enabling professionals in the field to apply robust statistical techniques to real-world problems.

CLINICAL PHARMACOKINETICS, published by ADIS INT LTD, is a premier journal dedicated to the field of pharmacology, with a distinguished reputation since its inception in 1976. With an impressive impact factor and categorized in the Q1 quartile for both general pharmacology and medical pharmacology, this journal ranks #29 out of 272 and #53 out of 313 in its respective categories in Scopus, highlighting its high academic influence and the quality of research it publishes. CLINICAL PHARMACOKINETICS serves as a vital resource for researchers, professionals, and students interested in the latest advancements in drug metabolism, therapeutic efficacy, and clinical applications of pharmacokinetic studies. As it continues to evolve through 2024 and beyond, the journal remains committed to fostering a deeper understanding of pharmacotherapy and its implications in clinical practice. While it does not currently offer open access, the journal ensures that cutting-edge research is accessible through various academic platforms.

INTERNATIONAL STATISTICAL REVIEW is a prestigious journal published by Wiley, recognized for its significant contributions to the field of statistics and probability. With an impact factor reflecting its high citation rate and ranking in the top quartile (Q1) of relevant categories, this journal is a vital resource for researchers, professionals, and students alike. Covering a broad range of topics within statistical theory and application, it aims to disseminate innovative research findings and methodological advancements that shape the discipline. The journal's extensive history, converging years from 1982 to 2024, establishes its longstanding commitment to fostering scholarly communication in statistics. While it operates under a subscription model, its rigorous peer-review process ensures that published articles are of the highest quality, providing readers with insightful, reliable, and impactful content. For those looking to stay at the forefront of statistical research, the INTERNATIONAL STATISTICAL REVIEW is an indispensable addition to their academic resources.

Statistics and Its Interface, issn 1938-7989, published by INT PRESS BOSTON, INC, is a vital academic journal dedicated to bridging the critical intersection of statistics, applied mathematics, and interdisciplinary research. With its inaugural publication in 2011, this journal has continually aimed to provide a platform for innovative statistical methods and their application across various fields, offering valuable insights for researchers and practitioners alike. While the journal currently operates without an open access model, it maintains an essential position within the scholarly community, evidenced by its 2023 rankings in the third quartile for Applied Mathematics and the fourth quartile for Statistics and Probability. Furthermore, it holds a respectable position in Scopus rankings, reflecting its commitment to quality over quantity. By publishing cutting-edge research, Statistics and Its Interface serves as a critical resource for advancing statistical knowledge and cultivating a deeper understanding of its applications in real-world contexts.